The tepid results could also be problematic for Chinese officials, given that they had touted the efficacy of the vaccines made by Sinovac and Sinopharm. Even though the vaccines had not received regulatory approval, and data from late-stage trials had not been made public, Beijing gave them to thousands of Chinese people under an emergency use policy; it plans to vaccinate 50 million people by the middle of next month.State media in China played down the news from Brazil. Global Times, a state-owned nationalist tabloid, ran a headline that said the Sinovac vaccine was “100 percent effective in preventing severe cases, …
